Primary Site >> Liver Cancer
Gene >> ADM
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: [HBs antigen-positive adult type liver cancer in a child with sustained remission induced by infusion of antineoplastic agents into the hepatic artery]. PMID: 6307170 Ref: [Evaluation of prognostic factors in hepatocellular carcinoma using multiple regression analysis]. PMID: 6308309 |
Ref: [Arterial infusion method: its theory and clinical application--dosage and regimen]. PMID: 2580487 Ref: [Low-dose intermittent intra-arterial infusion chemotherapy]. PMID: 2996438 Ref: [Experimental and clinical study of reduction surgery combined with chemotherapy of primary liver cancer]. PMID: 3932713 |
Ref: [Reduction surgery combined with chemotherapy of liver cancer]. PMID: 3119451 |
Ref: [Repeated arterial infusion therapy with ADM and CDDP in liver cancer using implanted reservoir]. PMID: 2843108 Ref: [Arterial infusion of anticancer agent and lipiodol using a totally implanted drug delivery system]. PMID: 2843118 |
Ref: [Clinical study of intrahepatic arterial infusion of unresectable hepatoblastoma and hepatocarcinoma in children]. PMID: 2476963 Ref: [Availability of intermittent chemotherapy by reservoir in liver metastasis of colo-rectal cancer]. PMID: 2506825 Ref: [Study of long-survival cases with liver metastasis of colorectal cancer by hepatic arterial infusion chemotherapy]. PMID: 2506832 Ref: [Reservoir implanted arterial infusion therapy in liver cancer with replaced right hepatic artery]. PMID: 2506833 Ref: [Non-surgical (medical) treatment of hepatocellular carcinoma (HCC)]. PMID: 2536269 Ref: [New approach for unresectable primary liver cancer--intra-arterial combination chemotherapy during and after operation with local injection of ethanol]. PMID: 2551220 Ref: [Usefulness of subcutaneously implanted reservoir for postoperative therapy in hepatocellular carcinoma and liver metastases of colorectal carcinoma]. PMID: 2551221 |
Ref: [A case of remission in metastatic lung tumor from hepatocellular carcinoma after combined CDDP and PSK therapy]. PMID: 1690825 |
Ref: [A case of recurrent hepatocellular carcinoma after hepatic resection surviving over five years by hepatic arterial infusion of lipiodol-anticancer drug suspension]. PMID: 1648891 Ref: [Studies on postoperative arterial infusion chemotherapy using implanted reservoir for hepatocellular carcinoma]. PMID: 1652223 Ref: [Study of intermittent intra-arterial infusion chemotherapy in liver metastases from squamous cell carcinoma]. PMID: 1888184 |
Ref: [Prophylactic chemotherapy by regional arterial infusion in resected hepatoma patients]. PMID: 1326914 Ref: [Significance of antitumor effects and immunological response on endogenously induced LAK therapy for primary or metastatic liver tumor]. PMID: 1530292 Ref: [A pharmacokinetic study of intra-arterial chemotherapy for prophylactic treatment of liver metastasis after hepatectomy for liver cancer]. PMID: 1530304 |
Ref: Cytotoxicity of paclitaxel in comparison with other anticancer agents against neoplastic cells obtained from clinical gastrointestinal carcinoma tissue. PMID: 8572592 |
Ref: [Chemosensitivity test on hepatocellular carcinoma (HCC) and drug resistance]. PMID: 8996838 |
Ref: [Relieving effect of sodium thiosulfate on transarterial chemotherapeutic emesis]. PMID: 9304980 |
Ref: Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma. PMID: 11202797 |
Ref: [A surgery oriented serial treatments of 191 patients with large primary liver cancer]. PMID: 11810776 |
Ref: [Phase III clinical study of a new anticancer drug atofluding]. PMID: 12520746 Ref: Serial therapies oriented by surgery for large primary liver carcinoma. PMID: 14607717 |
Ref: [Early effect of intra-arterial chemotherapy combined with degradable starch microspheres for malignant hepatic tumors]. PMID: 12557709 |
Ref: Experimental study of a novel thermotherapy for hepatocellular carcinoma using a magnesium ferrite complex powder that produces heat under a magnetic field. PMID: 15532799 Ref: [A case of Vp3 hepatocellular carcinoma with a good QOL after multidisciplinary treatments]. PMID: 15553758 |
Ref: [A successful case of more than 5 years of disease free survival in hepatocellular carcinoma with tumor thrombus to the right main branch of portal vein after repeated hepatic resection following transhepatic arterial embolization (TAE)]. PMID: 16315952 |
Ref: [A case of effective multidisciplinary treatment with hepatic resection for synchronous multiple liver metastases from rectal cancer]. PMID: 17033241 |
Ref: [Value of perioperative adjuvant therapy in liver transplantation for advanced hepatocellular carcinoma]. PMID: 17545034 Ref: Clinical outcomes of ATP-tumor chemosensitivity assay directed chemotherapy in hepatocellular carcinoma. PMID: 24557668 |
Ref: Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis. PMID: 23381014 Ref: The histone demethylase JMJD1A regulates adrenomedullin-mediated cell proliferation in hepatocellular carcinoma under hypoxia. PMID: 23583388 Ref: Interferon-alpha sensitizes HBx-expressing hepatocarcinoma cells to chemotherapeutic drugs through inhibition of HBx-mediated NF-kappaB activation. PMID: 23718853 Ref: Treatment of undifferentiated embryonal sarcoma of the liver in children--single center experience. PMID: 24210186 |
Ref: ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YA. PMID: 25473899 Ref: B4G2 induces mitochondrial apoptosis by the ROS-mediated opening of Ca(2+)-dependent permeability transition pores. PMID: 26382946 |
Ref: Targeted imaging and induction of apoptosis of drug-resistant hepatoma cells by miR-122-loaded graphene-InP nanocompounds. PMID: 28114997 Ref: Dalbinol, a rotenoid from Amorpha fruticosa L., exerts anti-proliferative activity by facilitating beta-catenin degradation in hepatocellular carcinoma cells. PMID: 28548956 Ref: CDKN2B is critical for verapamil-mediated reversal of doxorubicin resistance in hepatocellular carcinoma. PMID: 29299129 |
Ref: A vascular disrupting agent overcomes tumor multidrug resistance by skewing macrophage polarity toward the M1 phenotype. PMID: 29337108 Ref: miR-505 enhances doxorubicin-induced cytotoxicity in hepatocellular carcinoma through repressing the Akt pathway by directly targeting HMGB1. PMID: 29803174 |